RESPeRATE
PrivateLast Round
IPO Announced
Jul 31, 2007
Est. Valuation
$66M
Total Funding Raised
$12.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RESPeRATE is a medical device company that provides an FDA-cleared, non-drug device for lowering blood pressure through patented, device-guided breathing technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Health IoT, Consumer Electronics
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RESPeRATE Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
RESPeRATE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Jul 31, 2007 | ||||
| Series C | Apr 14, 2005 | ||||
| Series B | Oct 30, 2001 | ||||
| Series A | Jan 5, 2000 |
RESPeRATE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| I.B.I. - Managing & Underwriting Ltd. | IPO |
| 日本ベンチャーキャピタル株式会社 | Series C |
| Paladin Capital Group | Series B |
| Palladin Consumer Retail Partners | IPO |
| Ant Capital Partners | Series C |
| Medica Venture Partners | IPO, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 39% MoM, reaching 39.8K.
- Jul 31, 2007
$16M raised with I.B.I. as lead investor.
RESPeRATE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RESPeRATE's valuation, stock price, and market status.